Evidence map›Paper›PMID 35749590›Full record

ArticleMolecular biology and evolution2022

Accurate Identification of Subclones in Tumor Genomes.

Navid Ahmadinejad, Shayna Troftgruben, Junwen Wang, Pramod B Chandrashekar, Valentin Dinu, Carlo Maley, Li Liu

Open access · goldAbstract read
In one paragraph

Article in Molecular biology and evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Navid AhmadinejadCollege of Health Solutions, Arizona State University, Phoenix, AZ 85054, USA.
Shayna TroftgrubenCollege of Health Solutions, Arizona State University, Phoenix, AZ 85054, USA.
Junwen WangCollege of Health Solutions, Arizona State University, Phoenix, AZ 85054, USA.ORCID 0000-0002-4432-4707
Pramod B ChandrashekarCollege of Health Solutions, Arizona State University, Phoenix, AZ 85054, USA.ORCID 0000-0002-0175-0423
Valentin DinuCollege of Health Solutions, Arizona State University, Phoenix, AZ 85054, USA.
Carlo MaleyBiodesign Institute, Arizona State University, Tempe, AZ 85281, USA.ORCID 0000-0002-0745-7076
Li LiuCollege of Health Solutions, Arizona State University, Phoenix, AZ 85054, USA.ORCID 0000-0003-4002-7497
Arizona State University · USMayo Clinic in Arizona · US

Funding

The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO, SHIBATA, DARRYL K · 2018 to 2022
$8.6M
Discover and Analyze Germline-Somatic Interactions in CancerR01LM013438 · NLM · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI LIU, LI, YANG, PING · 2021 to 2023
$1.0M
NCI NIH HHS U54 CA217376NLM NIH HHS R01 LM013438
6 · The paper itself

Abstract

Understanding intratumor heterogeneity is critical for studying tumorigenesis and designing personalized treatments. To decompose the mixed cell population in a tumor, subclones are inferred computationally based on variant allele frequency (VAF) from bulk sequencing data. In this study, we showed that sequencing depth, mean VAF, and variance of VAF of a subclone are confounded. Without considering this effect, current methods require deep-sequencing data (>300× depth) to reliably infer subclones. Here, we present a novel algorithm that incorporates depth-variance and mean-variance dependencies in a clustering error model and successfully identifies subclones in tumors sequenced at depths of as low as 30×. We implemented the algorithm as a model-based adaptive grouping of subclones (MAGOS) method. Analyses of computer simulated data and empirical sequencing data showed that MAGOS outperformed existing methods on minimum sequencing depth, decomposition accuracy, and computation efficiency. The most prominent improvements were observed in analyzing tumors sequenced at depths between 30× and 200×, whereas the performance was comparable between MAGOS and existing methods on deeply sequenced tumors. MAGOS supports analysis of single-nucleotide variants and copy number variants from a single sample or multiple samples of a tumor. We applied MAGOS to whole-exome data of late-stage liver cancers and discovered that high subclone count in a tumor was a significant risk factor of poor prognosis. Lastly, our analysis suggested that sequencing multiple samples of the same tumor at standard depth is more cost-effective and robust for subclone characterization than deep sequencing a single sample. MAGOS is available at github (https://github.com/liliulab/magos).

Indexed as

High-Throughput Nucleotide SequencingNeoplasmsDNA Copy Number VariationsExomeGenomeHumansPolymorphism, Single Nucleotidecancer evolution, genomics, statistical modeling

Identifiers

PMID35749590
PMCPMC9260306
OpenAlexW4283383282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.